Structural determinants of Vibrio cholerae FeoB nucleotide promiscuity
Journal of Biological Chemistry · 2024
DOI: 10.1016/j.jbc.2024.107663 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Mark Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, University of Maryland, Baltimore County, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Vibrio cholerae, Bacterial Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Ferrous iron (Fe2+) is required for the growth and virulence of many pathogenic bacteria, including Vibrio cholerae (Vc), the causative agent of the disease cholera. For this bacterium, Feo is the primary system that transports Fe2+ into the cytosol. FeoB, the main component of this system, is regulated by a soluble cytosolic domain termed NFeoB. Recent reanalysis has shown that NFeoBs can be classified as either GTP-specific or NTP-promiscuous, but the structural and mechanistic bases for these differences were not known. To explore this intriguing property of FeoB, we solved the X-ray crystal structures of VcNFeoB in both the apo and the GDP-bound forms. Surprisingly, this promiscuous NTPase displayed a canonical NFeoB G-protein fold like GTP-specific NFeoBs. Using structural bioinformatics, we hypothesized that residues surrounding the nucleobase could be important for both nucleotide affinity and specificity. We then solved the X-ray crystal structures of N150T VcNFeoB in the apo and GDP-bound forms to reveal H-bonding differences surrounding the guanine nucleobase. Interestingly, isothermal titration calorimetry revealed similar binding thermodynamics of the WT and N150T proteins to guanine nucleotides, while the behavior in the presence of adenine nucleotides was dramatically different. AlphaFold models of VcNFeoB in the presence of ADP and ATP showed important conformational changes that contribute to nucleotide specificity among FeoBs. Combined, these results provide a structural framework for understanding FeoB nucleotide promiscuity, which could be an adaptive measure utilized by pathogens to ensure adequate levels of intracellular iron across multiple metabolic landscapes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, University of Maryland, Baltimore County, Baltimore, Maryland, USA.
- Department of Molecular Biosciences, University of Texas at Austin, Austin, Texas, USA.
- Department of Molecular Biosciences, University of Texas at Austin, Austin, Texas, USA; John Ring LaMontagne Center for Infectious Disease, University of Texas at Austin, Austin, Texas, USA.
- Department of Chemistry and Biochemistry, University of Maryland, Baltimore County, Baltimore, Maryland, USA. Electronic address: smitha@umbc.edu.
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- National Institute of General Medical Sciences
- Argonne National Laboratory
- National Science Foundation
- Office of Science
- National Institute of Allergy and Infectious Diseases
- Michigan Technology Tri-Corridor
Zitieren
APA
Lee, M., Magante, K., Gómez-Garzón, C., Payne, S. M., & Smith, A. T. (2024). Structural determinants of Vibrio cholerae FeoB nucleotide promiscuity. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.107663
Vancouver
Lee M, Magante K, Gómez-Garzón C, Payne SM, Smith AT. Structural determinants of Vibrio cholerae FeoB nucleotide promiscuity. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2024.107663
BibTeX
@article{Lee2024,
author = {Lee, Mark and Magante, Kate and Gómez-Garzón, Camilo and Payne, Shelley M and Smith, Aaron T},
title = {Structural determinants of Vibrio cholerae FeoB nucleotide promiscuity},
journal = {Journal of Biological Chemistry},
year = {2024},
doi = {10.1016/j.jbc.2024.107663}
}
EUVIMED